Climate Change Data

Environmental Metrics

ESG Focus Areas

• Providing better cancer treatments
• Being a responsible employer
• Evaluating and monitoring our suppliers

Social Achievements

• Positive relations with employees, supporting their development, well-being, and job satisfaction; striving for an ethical and inclusive workplace.

Governance Achievements

• Transitioned to IFRS accounting standards.

Climate Goals & Targets

Environmental Challenges

• General uncertainty related to research and development, including clinical trial delays, and financing and capital acquisition for operations.
• The spread of COVID-19.

Mitigation Strategies

• No delays in clinical trials or development projects due to COVID-19.
• Successful capital raising through directed and preferential share issues.

Supply Chain Management

Responsible Procurement

• Following pharmaceutical standards set by regulatory authorities (FDA, EMA); adhering to industry guidelines covering development, clinical trials, manufacturing, and drug handling.

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: IFRS

UN Sustainable Development Goals

• Goal 3: Good health and well-being

Developing effective cancer treatments with fewer side effects and improved quality of life for patients.

Environmental Metrics

ESG Focus Areas

• Patient
• Planet
• People – employees
• Partnerships

Social Achievements

• Improved gender balance in the board (33% women) and management (100% women).

Governance Achievements

• Established an incentive program for key personnel.

Climate Goals & Targets

Environmental Challenges

• Clinical trial timelines and costs.
• Dependence on subcontractors for drug production.
• Regulatory approvals.
• Dependence on key personnel.
• Patent protection and intellectual property risks.
• Capital requirements for drug development.

Mitigation Strategies

• Ongoing efforts to secure partnerships and funding.
• Continuous monitoring of financial risks.
• Diversification of suppliers.
• Active recruitment and retention strategies for key personnel.
• Robust patent portfolio and ongoing IP development.
• Securing financing through directed share issues and convertible loan agreements.

Supply Chain Management

Supplier Audits: LIDDS conducts audits to ensure suppliers meet quality standards.

Responsible Procurement

• LIDDS relies on sustainable and robust suppliers for production, packaging, and distribution of study drugs.

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: UN Sustainable Development Goals

Certifications: ISO 14001 (one contract manufacturer)

UN Sustainable Development Goals

• 3
• 8
• 13
• 17

LIDDS's activities contribute to these SDGs through its focus on improving patient health, economic growth through partnerships, climate action through efficient resource use, and partnerships for sustainable development.

Sustainable Products & Innovation

• NanoZolid technology for more precise and efficient drug delivery.

Environmental Metrics

ESG Focus Areas

• Patient
• Planet
• People
• Partnership

Social Achievements

• Improved gender distribution in management (50% men/50% women) and company (43% men/57% women).

Governance Achievements

• Added two new board members in 2022: Johan Lund and Max Mitteregger.

Climate Goals & Targets

Environmental Challenges

• Difficult financial market conditions impacting securing risk capital.
• Dependence on out-licensing agreements for revenue generation.
• Dependence on external suppliers for various services in drug development.
• Dependence on key personnel.
• Risks related to clinical trials (delays, unexpected costs, unfavorable results).
• Regulatory approval processes.
• Potential for competitors to circumvent patents.

Mitigation Strategies

• Successful rights issue in 2023 to secure funding.
• Collaboration with Alira Health for business development and licensing.
• Continuous review and renewal of policies and systems to maintain high standards.
• Focus on recruiting and retaining qualified staff.
• Ongoing evaluation of different financing solutions.

Supply Chain Management

Responsible Procurement

• Compliance and high standards expected from suppliers.
• Verification of supplier compliance with environmental and quality standards before collaboration.

Climate-Related Risks & Opportunities

UN Sustainable Development Goals

• Goal 3: Good health and well-being

Developing more effective and safer cancer treatments with fewer side effects and improved quality of life for patients.